Developing HTA Guidelines for Rare Disease Therapies - an Industry Perspective
Abstract
Authors
CB Taylor AR Weston C Milliner S Schulz F Clark A Goodall A Brown L Chim D Kwasha E Quinn T McDonnell K Evans
CB Taylor AR Weston C Milliner S Schulz F Clark A Goodall A Brown L Chim D Kwasha E Quinn T McDonnell K Evans
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now